ANL
Adlai Nortye Ltd.NASDAQHealthcare$8.18+10.02%ClosedMarket Cap: $255.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.76
P/S
0.00
EV/EBITDA
-5.15
DCF Value
$2.36
FCF Yield
-18.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-99.0%
ROA
-72.8%
ROIC
-104.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2024 | $0.00 | -Infinity% | $-54.9M | $-51.9M | $-4.89 | — |
| Q2 2024 | $745.0K | 100.0% | $-14.6M | $-13.8M | $-1.59 | — |
| Q1 2024 | $745.0K | 100.0% | $-14.6M | $-13.8M | $-1.59 | — |
| Q4 2023 | $2.5M | 100.0% | $-17.7M | $-13.2M | $-1.95 | — |
| FY 2023 | $5.0M | 100.1% | $-67.6M | $-104.9M | $-15.42 | — |
| Q3 2023 | $2.5M | 100.0% | $-17.7M | $-13.2M | $-1.95 | — |
| Q2 2023 | $0.00 | -Infinity% | $-16.9M | $-63.4M | $-7.47 | — |
| Q1 2023 | $0.00 | -Infinity% | $-15.3M | $-15.0M | $-1.77 | — |
| Q4 2022 | $0.00 | NaN% | $-19.2M | $-22.1M | $-2.61 | — |
| FY 2022 | $0.00 | -Infinity% | $-67.3M | $-58.8M | $-6.93 | — |
| Q3 2022 | $0.00 | NaN% | $-19.2M | $-22.1M | $-2.61 | — |
| Q2 2022 | $0.00 | NaN% | $-17.5M | $-3.5M | $-0.41 | — |